JPWO2023019259A5 - - Google Patents
Info
- Publication number
- JPWO2023019259A5 JPWO2023019259A5 JP2024508498A JP2024508498A JPWO2023019259A5 JP WO2023019259 A5 JPWO2023019259 A5 JP WO2023019259A5 JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024508498 A JP2024508498 A JP 2024508498A JP WO2023019259 A5 JPWO2023019259 A5 JP WO2023019259A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- methylmorpholin
- cancer
- alkyl
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232983P | 2021-08-13 | 2021-08-13 | |
| US63/232,983 | 2021-08-13 | ||
| US202263317500P | 2022-03-07 | 2022-03-07 | |
| US63/317,500 | 2022-03-07 | ||
| PCT/US2022/074925 WO2023019259A1 (en) | 2021-08-13 | 2022-08-12 | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532780A JP2024532780A (ja) | 2024-09-10 |
| JPWO2023019259A5 true JPWO2023019259A5 (https=) | 2025-08-18 |
| JP2024532780A5 JP2024532780A5 (https=) | 2025-08-18 |
Family
ID=83188606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508498A Pending JP2024532780A (ja) | 2021-08-13 | 2022-08-12 | Ｖｐｓ３４阻害剤を使用した併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250127790A1 (https=) |
| EP (1) | EP4384180A1 (https=) |
| JP (1) | JP2024532780A (https=) |
| AU (1) | AU2022326573A1 (https=) |
| CA (1) | CA3228766A1 (https=) |
| TW (1) | TW202320797A (https=) |
| WO (1) | WO2023019259A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2630970A (en) * | 2023-06-15 | 2024-12-18 | Duke Street Bio Ltd | PARP1 inhibitor compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015108881A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| DK3416957T3 (da) | 2016-02-19 | 2020-09-21 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes |
| WO2019038387A1 (en) * | 2017-08-23 | 2019-02-28 | Sprint Bioscience Ab | PYRIDYLPYRIDONE COMPOUNDS |
| CN111094271B (zh) * | 2017-08-23 | 2023-02-28 | 思普瑞特生物科学公司 | 吡啶胺-吡啶酮化合物和嘧啶胺-吡啶酮化合物 |
| WO2020008046A1 (en) * | 2018-07-06 | 2020-01-09 | Sprint Bioscience Ab | Biomarker |
-
2022
- 2022-08-12 AU AU2022326573A patent/AU2022326573A1/en active Pending
- 2022-08-12 US US18/683,078 patent/US20250127790A1/en active Pending
- 2022-08-12 TW TW111130481A patent/TW202320797A/zh unknown
- 2022-08-12 JP JP2024508498A patent/JP2024532780A/ja active Pending
- 2022-08-12 CA CA3228766A patent/CA3228766A1/en active Pending
- 2022-08-12 EP EP22764625.4A patent/EP4384180A1/en active Pending
- 2022-08-12 WO PCT/US2022/074925 patent/WO2023019259A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7074801B1 (en) | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | |
| JP2025143253A (ja) | Ｂｒｍ標的化化合物および関連使用方法 | |
| US7838524B2 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
| JP2021119196A5 (https=) | ||
| TW200534853A (en) | Synergistic methods and compositions for treating cancer | |
| JP2010513444A5 (https=) | ||
| AU2020202167A1 (en) | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors | |
| JP2019505595A5 (https=) | ||
| HRP20201430T1 (hr) | Spojevi 6-heterociklil-4-morfolin-4-ilpiridin-2-ona korisni za liječenje karcinoma i dijabetesa | |
| RU2507204C2 (ru) | Положительные аллостерические модуляторы м1-рецепторов на основе пираниларилметилбензохиназолинона | |
| RU2016137674A (ru) | Производные пиперидиндиона | |
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| IL303196B2 (en) | Heteroaryl-substituted pyridines and methods of use | |
| RU2413726C2 (ru) | Замещенные биарильные аналоги пиперазинилпиридина, их применение в терапии, фармацевтическая композиция, фармацевтический препарат, способы уменьшения проводимости кальция и ингибирования связывания капсаициновых рецепторов | |
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| SI3083586T1 (en) | The new carboxamides, the process of their manufacture, the pharmaceutical preparations they contain and their use for the manufacture of medicinal products | |
| RU2009125897A (ru) | Ингибиторы фосфоинозитид-3-киназы и способы их применения | |
| EA013231B1 (ru) | Замещенные амидные производные в качестве ингибиторов протеинкиназы | |
| IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| JP2007505874A5 (https=) | ||
| KR20120049940A (ko) | 키나제 억제제로서의 헤테로아릴 화합물 | |
| JP2017500364A5 (https=) | ||
| HRP20221454T1 (hr) | Piridinamin-piridonski i pirimidinamin-piridonski spojevi | |
| JP2009544626A (ja) | Ｉｔｐｋｂ阻害剤としての化合物および組成物 | |
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета |